Lead by Marcela Maus, MD, PhD and Matthew Frigault, MD, the Cellular Immunotherapy Program brings together physicians and laboratory scientists focused on immune cell engineering and its clinical effects.

Leadership

Marcela Maus

Marcela Maus, MD, PhD
Director, Cellular Immunotherapy Program
Mass General Cancer Center

 

 

Learn more about Marcela Maus, MD, PhD

Marcela Maus, MD, PhD
Director, Cellular Immunotherapy Program
Paula O’Keeffe Chair in Oncology

Attending Physician
Hematopoietic Cell Transplant & Cell Therapy Program
Massachusetts General Hospital

Associate Member, Broad Institute of MIT and Harvard
Professor of Medicine, Harvard Medical School

Associate Head & Head of Cell Therapies, Gene and Cell Therapy Institute, Mass General Brigham

Marcela Maus

Dr. Maus is the Paula O'Keeffe Endowed Chair of the Massachusetts General Hospital Cancer Center and the Director of the Cellular Immunotherapy Program. She is also a Professor of Hematology and Oncology at Massachusetts General Hospital and Harvard Medical School, where she runs a laboratory focused on developing and improving CAR T cell therapy for cancer patients while also periodically attending for the bone marrow transplant service. Dr. Maus grew up in New York, NY and attended Massachusetts Institute of Technology for her undergraduate degree in Biology and Literature. She then earned her MD, PhD from the University of Pennsylvania School of Medicine under the direction of her PhD mentor, Dr. Carl June. She then did a one-year postdoctoral fellowship with Dr. Kathy High at the Children’s Hospital of Philadelphia, completed her clinical training in internal medicine, hematology, and oncology as a resident at the University of Pennsylvania Health System, and was a fellow at Memorial Sloan Kettering Cancer Center in Dr. Michel Sadelain’s lab.

Following her extensive training, Marcela returned to the University of Pennsylvania in 2012 to expand research efforts in the development of CAR T cells for lymphoma, myeloma, and other cancers. While there, Marcela continued her efforts on the preclinical development of CAR T cells and correlative studies of CAR T cell-related toxicities and resistance to therapies. Now, Dr. Maus runs a laboratory focused on developing and improving CAR T cell therapy for cancer patients. She has won numerous awards for her transformative research and is achieving her goal of using science to determine the best way to treat patients by harnessing the power of the immune system to solve intractable problems like cancer. She also enjoys training clinicians and scientists and watching her mentees succeed and become independent scientists and collaborators. Marcela is also a mother to three children, one large dog and one gecko. In her free time, Marcela enjoys spending time with her husband, kids, and pets, gardening, and skiing.

 

Matthew Frigault, MD

Matthew Frigault, MD
Administrative Director, Cellular Therapy Service
Mass General Cancer Center

 

 


Investigator and Physician Team

To bring therapies to patients, a dedicated team of early-phase clinical investigators in oncology play a central role in cancer immunology at Mass General.

Clinical Directors

Jeremy Abramson

Jeremy Slade Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma
Mass General Cancer Center

 

 

Patricia Brunker, MD, DPhil
Director, Blood Transfusion Center
Mass General Hospital

 

 

Yi-Bin Chen

Yi-Bin Chen, MD
Director, Hematopoietic Cell Transplant & Cell Therapy Program
Mass General Cancer Center

 

 

Edwin Choy, MD, PhD

Edwin Choy, MD, PhD
Director, Center for Sarcoma and Connective Tissue Oncology
Mass General Cancer Center

 

 

William Curry, MD

William Curry, MD
Director, Neurosurgical Oncology
Mass General Hospital

 

 

Amir Fathi

Amir Fathi, MD
Director, Center for Leukemia
Mass General Cancer Center

 

 

Matthew Frigault, MD

Matthew Frigault, MD
Administrative Director, Cellular Therapy Service
Mass General Cancer Center

 

 

Justin Gainor

Justin F. Gainor, MD
Director, Center for Thoracic Cancers
Mass General Cancer Center

 

 

Tim Graubert

Tim Graubert, MD
Director, Hematologic Malignancy Program
Mass General Cancer Center

 

 

Donald Lawrence, MD

Donald Lawrence, MD
Clinical Director, Center for Melanoma
Mass General Cancer Center

 

 

Marcel Maus

Marcela Maus, MD, PhD
Director, Cellular Immunotherapy Program
Mass General Cancer Center

 

 

Noopur Raje

Noopur Suresh Raje, MD
Director, Center for Multiple Myeloma
Mass General Cancer Center

 

 

Ryan Sullivan

Ryan J. Sullivan, MD
Director, Center for Melanoma
Mass General Cancer Center

 

 

Lori Wirth, MD

Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Mass General Cancer Center

 

 

Research Directors

Magdi Elsallab, MD, PhD

Magdi Elsallab, MD, PhD
Director, Process Development Lab
Lab Director, Cellular Therapy and Transplantation Laboratory
Mass General Cancer Center

 

Kathleen Gallagher

Kathleen Gallagher, PhD
Director, Immune Monitoring Laboratory
Mass General Cancer Center

 

 

Thomas Spitzer, MD

Thomas Spitzer, MD
Medical Director, Cellular Therapy and Transplantation Laboratory
Mass General Cancer Center

 

 

Physician Team

Inas Abuali, MBCHB
Mass General Cancer Center

 

 

Philip Amrein, MD

Philip Amrein, MD
Center for Leukemia
Mass General Cancer Center

 

 

Andrew Branagan, MD, PhD

Andrew Branagan, MD, PhD
Center for Multiple Myeloma
Mass General Cancer Center

 

 

Bryan Choi, MD, PhD

Bryan Choi, MD, PhD
Department of Neurosurgery
Mass General Hospital

 

 

Diana Cirstea, MD

Diana Cirstea, MD
Center for Multiple Myeloma
Mass General Cancer Center

 

 

Gregory Cote, MD, PhD

Gregory Cote, MD, PhD
Center for Sarcoma and Connective Tissue Oncology
Mass General Cancer Center

 

 

Elijah Darnell, MD
Fellow
Mass General Cancer Center

 

 

Zachariah DeFilipp, MD

Zachariah DeFilipp, MD
Bone Marrow Transplant Program
Mass General Cancer Center

 

 

Tejaswini More Dhawale, MD

Tejaswini More Dhawale, MD
Mass General Cancer Center

 

 

Jorg Dietrich, MD, PhD

Jorg Dietrich, MD, PhD
Pappas Center for Neuro-Oncology
Mass General Cancer Center

 

 

Areej El-Jawahri, MD

Areej El-Jawahri, MD
Bone Marrow Transplant Program
Mass General Cancer Center

 

 

Xin Gao, MD

Xin Gao, MD
Claire and John Bertucci Center for Genitourinary Cancers
Mass General Cancer Center

 

 

"Elizabeth

Elizabeth Gerstner, MD
Pappas Center for Neuro-Oncology
Mass General Cancer Center

 

 

Alexandra Haugh, MD, MPH

Alexandra Haugh, MD, MPH
Center for Melanoma
Mass General Cancer Center

 

 

Erika Haydu, MD, PhD

Erika Haydu, MD, PhD
Jon and Jo Ann Hagler Center for Lymphoma
Mass General Cancer Center

 

 

Salvia Jain, MD

Salvia Jain, MD
Jon and Jo Ann Hagler Center for Lymphoma
Mass General Cancer Center

 

 

Patrick Connor Johnson, MD

Patrick Connor Johnson, MD
Jon and Jo Ann Hagler Center for Lymphoma
Mass General Cancer Center

 

 

Michael Lanuti, MD

Michael Lanuti, MD
Division of Thoracic Surgery
Mass General Hospital

 

 

Mark Leick

Mark Leick, MD
Bone Marrow Transplant Program
Mass General Cancer Center

 

 

Steven McAfee, MD

Steven McAfee, MD
Clinical Director, Bone Marrow Transplant Program
Mass General Cancer Center

 

 

Rupa Narayan, MD

Rupa Narayan, MD
Center for Leukemia
Mass General Cancer Center

 

 

Richard Newcomb, MD

Richard Newcomb, MD
Bone Marrow Transplant Program
Mass General Cancer Center

 

 

Paul O'Donnell, MD, PhD
Mass General Cancer Center

 

 

Chirayu Patel, MD, MPH

Chirayu Patel, MD, MPH
Department of Radiation Oncology
Mass General Cancer Center

 

 

Benjamin Puliafito

Benjamin Puliafito, MD
Center for Multiple Myeloma
Mass General Cancer Center

 

 

Meghan Sise, MD

Meghan Sise, MD
Division of Nephrology
Mass General Hospital

 

 

Jacob Soumerai, MD

Jacob Soumerai, MD
Jon and Jo Ann Hagler Center for Lymphoma
Mass General Cancer Center

 

 

Oladapo Yeku, MD, PhD, FACP

Oladapo Yeku, MD, PhD, FACP
Center for Gynecologic Oncology
Mass General Cancer Center

 

 


Immune Monitoring Laboratory

The Immune Monitoring Laboratory is an essential and integral part of the Cellular Immunotherapy Program. The laboratory provides expertise to enable translational clinical studies of immune-based therapies, based on the highest standard operating systems.

Kathleen Gallagher

Kathleen Gallagher, PhD
Director, Immune Monitoring Laboratory
Mass General Cancer Center

 

 


Process Development Laboratory

Magdi Elsallab, MD, PhD

Magdi Elsallab, MD, PhD
Director, Process Development Lab
Lab Director, Cellular Therapy and Transplantation Laboratory
Mass General Cancer Center

 


Blood Transfusion Service

The Blood Transfusion Service is an FDA-licensed, full-service blood bank that consists of the Blood Donor Center, the Outpatient Infusion Unit, the Apheresis Unit, the Transfusion Service, and the Histocompatibility (HLA) Laboratory.

Patricia Brunker, MD, DPhil
Director, Blood Transfusion Center
Mass General Hospital

 

 


Cellular Therapy and Transplantation Laboratory

The Cellular Therapeutics and Transplantation Laboratory team plays an integral part in stem cell processing, transplant infusions and bone marrow harvests at Mass General Cancer Center.

Magdi Elsallab, MD, PhD

Magdi Elsallab, MD, PhD
Director, Process Development Lab
Lab Director, Cellular Therapy and Transplantation Laboratory
Mass General Cancer Center

 

Thomas Spitzer, MD

Thomas Spitzer, MD
Medical Director, Cellular Therapy and Transplantation Laboratory
Mass General Cancer Center